Brooklyn Investment Group Has $48,000 Position in Roche Holding AG (OTCMKTS:RHHBY)

Brooklyn Investment Group lifted its holdings in Roche Holding AG (OTCMKTS:RHHBY) by 36.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,354 shares of the company’s stock after buying an additional 363 shares during the period. Brooklyn Investment Group’s holdings in Roche were worth $48,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Bard Financial Services Inc. boosted its stake in shares of Roche by 37.7% during the 4th quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock valued at $3,866,000 after buying an additional 30,350 shares during the period. GAMMA Investing LLC boosted its position in Roche by 57.7% during the third quarter. GAMMA Investing LLC now owns 7,944 shares of the company’s stock valued at $317,000 after purchasing an additional 2,906 shares during the last quarter. Diversified Trust Co grew its stake in Roche by 6.4% in the third quarter. Diversified Trust Co now owns 59,742 shares of the company’s stock valued at $2,396,000 after purchasing an additional 3,613 shares in the last quarter. Norman Fields Gottscho Capital Management LLC raised its stake in shares of Roche by 5.5% during the 3rd quarter. Norman Fields Gottscho Capital Management LLC now owns 26,000 shares of the company’s stock worth $1,039,000 after purchasing an additional 1,350 shares in the last quarter. Finally, Canopy Partners LLC lifted its holdings in shares of Roche by 4.6% during the 3rd quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock valued at $310,000 after buying an additional 344 shares during the last quarter.

Roche Stock Performance

Shares of RHHBY opened at $36.35 on Monday. Roche Holding AG has a 12 month low of $29.20 and a 12 month high of $42.43. The company’s fifty day moving average is $35.76 and its 200-day moving average is $38.04.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.